Riskpilot← Back to searchSign inGet full accessØRMELEN LEGESENTER AS
ASActiveOrg 997772679Tangenvegen 5, 7653 VerdalGeneral medical practice activities · NACE 8621Est. 20127 employees
Revenue 2024
NOK 3,5M
+3% vs 2023
EBITDA margin
0.7%
-31% vs 2023
Equity ratio
32.8%
Financial strength
Net profit 2024
NOK -3K
-129% vs 2023
| Revenue | NOK 3,5M | +3% |
| EBITDA | NOK 25K | -31% |
| Net profit | NOK -3K | -129% |
| Total assets | NOK 860K | -8% |
| Equity | NOK 282K | -1% |
| Employees | 7 | — |
Legal name
ØRMELEN LEGESENTER AS
Org number
997772679
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. januar 2012
Share capital
NOK 108 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive kontorfellesskap for samarbeidende leger ved ørmelen legesenter.
Address
Tangenvegen 5, 7653 Verdal
Phone
+4774075270
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 880 | 3 017 | 3 187 | 3 362 | 3 462 |
| Staff expenses | −1 496 | −1 621 | −1 611 | −1 765 | −1 859 |
| EBITDA | 6 | 57 | 46 | 37 | 25 |
| Depreciation & amort. | −16 | −68 | −40 | −21 | −21 |
| EBIT | −11 | −11 | 6 | 16 | 4 |
| Net financials | 0 | 0 | −0 | −0 | 0 |
| Profit before tax | −11 | −11 | 6 | 16 | 4 |
| Tax | −2 | −5 | 3 | 5 | 7 |
| Net profit | −8 | −6 | 3 | 11 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 849 | 803 | 827 | 931 | 860 |
| Equity | 278 | 272 | 275 | 285 | 282 |
| Long-term debt | 11 | 3 | 0 | 0 | 0 |
| Short-term debt | 560 | 528 | 552 | 646 | 578 |
| Total debt | 571 | 531 | 552 | 646 | 578 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20202024
Equity ratio
32.8%
This company
38.2%
Market median
+14% vs market
20202024
Return on equity
-1.1%
This company
18.4%
Market median
-106% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
4.03×
This company
1.12×
Market median
+260% vs market
20202024
Debt / equity
2.05×
This company
0.62×
Market median
-231% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2017 | |
| Chairman | 2017 | |
| Board of Directors | 2017 | |
| Former (1) | ||
| Board of Directors | 2017 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØRMELEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sunniva Nyberg Karlsen | Board of Directors | 0 companies |
| Eirik Røvde Solberg | Chairman | 0 companies |
| Roar Rismark | Board of Directors | 0 companies |
| Benedicte Agdestein | Board of Directors | 0 companies |